Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
TTLC 2019
IASLC 2019 Targeted Therapies of Lung Cancer Meeting
Access to all slides from presentations that occur during the IASLC 2019 Targeted Therapies of Lung Cancer Meeting in Santa Monica, CA
Presentation Date(s):- Feb 20 - 23, 2019
- Total Presentations: 232
-
+
21 - Faculty Dinner
- Type: General Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 2/22/2019, 20:15 - 20:15, Wedgewood Ballroom
-
+
Introduction Joan Schiller
19:15 - 19:15 | Author(s): Suresh Ramalingam
- Abstract
No abstract available for this presentation
-
+
Lung Cancer: As Seen Through the Eyes of Someone Who Has Seen This, Done That (Slides Available)
19:15 - 20:00 | Author(s): Joan Schiller
- Abstract
No abstract available for this presentation
-
+
22 - ICI Combinations (Stimulatory and Inhibitory)
- Type: General Session
- Track:
- Presentations: 22
- Slides Available
- Moderators:Mary Redman
- Coordinates: 2/23/2019, 08:00 - 09:50, Starlight Ballroom
-
+
Checkmate 227 (Slides Available)
07:00 - 07:05 | Author(s): Hossein Borghaei
- Abstract
No abstract available for this presentation
-
+
Durvalumab + Tremilimumab (Slides Available)
07:05 - 07:10 | Author(s): Natasha Leighl
- Abstract
No abstract available for this presentation
-
+
IO + LAG-3 (Slides Available)
07:10 - 07:15 | Author(s): Benjamin Creelan
- Abstract
No abstract available for this presentation
-
+
IO + CSF-1R (Slides Available)
07:15 - 07:20 | Author(s): Michael Cheng
- Abstract
No abstract available for this presentation
-
+
IO + GSK204691 (ICOS) (Slides Available)
07:20 - 07:25 | Author(s): Melissa Johnson
- Abstract
No abstract available for this presentation
-
+
IO + Adenosine (Slides Available)
07:25 - 07:30 | Author(s): Dwight Owen
- Abstract
No abstract available for this presentation
-
+
IO + IDO (Slides Available)
07:30 - 07:35 | Author(s): Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
IO + HDAC (Slides Available)
07:35 - 07:40 | Author(s): Liza Villaruz
- Abstract
No abstract available for this presentation
-
+
IO + Ramucirumab (Slides Available)
07:40 - 07:45 | Author(s): Karen Reckamp
- Abstract
No abstract available for this presentation
-
+
IO + Sitravantinib (Slides Available)
07:45 - 07:50 | Author(s): Kai He
- Abstract
No abstract available for this presentation
-
+
IO + Vorolonib
07:50 - 07:55 | Author(s): Leora Horn
- Abstract
No abstract available for this presentation
-
+
Anti- B7H3 (Slides Available)
07:55 - 08:00 | Author(s): Alex Adjei
- Abstract
No abstract available for this presentation
-
+
M7824 (TGF Beta)
08:00 - 08:05 | Author(s): Christine Hann
- Abstract
No abstract available for this presentation
-
+
IO + Niraparib (Slides Available)
08:05 - 08:10 | Author(s): Suresh Ramalingam
- Abstract
No abstract available for this presentation
-
+
IO + CD137 (Slides Available)
08:10 - 08:15 | Author(s): Vamsidhar Velcheti
- Abstract
No abstract available for this presentation
-
+
IO + GITR (Slides Available)
08:15 - 08:20 | Author(s): Joshua Bauml
- Abstract
No abstract available for this presentation
-
+
IO + OX40 (Slides Available)
08:20 - 08:25 | Author(s): Deborah Doroshow
- Abstract
No abstract available for this presentation
-
+
LYC55716 (RORgamma) (Slides Available)
08:25 - 08:30 | Author(s): Karen Kelly
- Abstract
No abstract available for this presentation
-
+
TSR-022 (Anti-TIM-3); Dostarlimab (Anti-PD-1) (Slides Available)
08:30 - 08:35 | Author(s): Edward Garon
- Abstract
No abstract available for this presentation
-
+
IO + EGFR TKI (Slides Available)
08:35 - 08:40 | Author(s): Jonathan Riess
- Abstract
No abstract available for this presentation
-
+
Science (Slides Available)
08:40 - 08:50 | Author(s): Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
AMG119 (DLL-3) (Slides Available)
08:50 - 09:00 | Author(s): Lauren Byers
- Abstract
No abstract available for this presentation
-
+
23 - FGFR/PDGFR/Angiogenesis
- Type: General Session
- Track:
- Presentations: 8
- Slides Available
- Moderators:Edward Kaftan
- Coordinates: 2/23/2019, 09:50 - 10:45, Starlight Ballroom
-
+
Ramucirumab Combos (Slides Available)
08:50 - 08:55 | Author(s): Edward Garon
- Abstract
No abstract available for this presentation
-
+
Bevacizumab Combos (Slides Available)
08:55 - 09:00 | Author(s): Glenwood Goss
- Abstract
No abstract available for this presentation
-
+
Nintedanib and Combos (Slides Available)
09:00 - 09:05 | Author(s): John D. Heymach
- Abstract
No abstract available for this presentation
-
+
Ponatinib (Slides Available)
09:05 - 09:10 | Author(s): Ryan Gentzler
- Abstract
No abstract available for this presentation
-
+
AZ4547 (Slides Available)
09:10 - 09:15 | Author(s): Vassiliki Papadimitrikopoulou
- Abstract
No abstract available for this presentation
-
+
INCB054828 (Slides Available)
09:15 - 09:20 | Author(s): Daniel Morgensztern
- Abstract
No abstract available for this presentation
-
+
Phase 1B Study of TRC 105 (Carotuximab) in Combination with Nivolumab in Patients with Metastatic NSCLC (Slides Available)
09:20 - 09:25 | Author(s): Francisco Robert
- Abstract
No abstract available for this presentation
-
+
Science (Slides Available)
09:25 - 09:35 | Author(s): John D. Heymach
- Abstract
No abstract available for this presentation
-
+
24 - Debate #4 NSCLC Patients With Solitary Liver Metastases and TPS 0 Should Receive CT+IO or CT+IO+Bev or CT+IO+Oligometastatic RT
- Type: General Session
- Track:
- Presentations: 3
- Slides Available
- Moderators:Wade Iams
- Coordinates: 2/23/2019, 11:00 - 11:20, Starlight Ballroom
-
+
CT + IO + Oligometastatic (Slides Available)
10:00 - 10:20 | Author(s): Jeffrey Bradley
- Abstract
No abstract available for this presentation
-
+
CT + IO (Slides Available)
10:00 - 10:20 | Author(s): Jeffrey Crawford
- Abstract
No abstract available for this presentation
-
+
CT + IO + Bev (Slides Available)
10:00 - 10:20 | Author(s): Primo Lara
- Abstract
No abstract available for this presentation
-
+
25 - PI3K, mTOR DNA Repair, CHK1/Wee1/CDK4/5/Bromodomain Inhibitors
- Type: General Session
- Track:
- Presentations: 16
- Slides Available
- Moderators:Ron Natale
- Coordinates: 2/23/2019, 11:20 - 13:00, Starlight Ballroom
-
+
AZD0156 (ATM) (Slides Available)
10:20 - 10:25 | Author(s): Kathryn Mileham
- Abstract
No abstract available for this presentation
-
+
PIK3/MTOR (Slides Available)
10:25 - 10:30 | Author(s): Helen Ross
- Abstract
No abstract available for this presentation
-
+
CC-223 (TORC1/2) (Slides Available)
10:30 - 10:35 | Author(s): Ron Natale
- Abstract
No abstract available for this presentation
-
+
TAK228 (TORC1/2) (Slides Available)
10:35 - 10:40 | Author(s): Paul Paik
- Abstract
No abstract available for this presentation
-
+
Gedatolisib (PI3K/MTOR) (Slides Available)
10:40 - 10:45 | Author(s): Zosia Piotrowska
- Abstract
No abstract available for this presentation
-
+
Buparlisib (PI3K) (Slides Available)
10:45 - 10:50 | Author(s): Parneet Cheema
- Abstract
No abstract available for this presentation
-
+
Taselisib (PI3K) (Slides Available)
10:50 - 10:55 | Author(s): Corey Langer
- Abstract
No abstract available for this presentation
-
+
AZD6738 (ATR) (Slides Available)
10:55 - 11:00 | Author(s): Terry Ng
- Abstract
No abstract available for this presentation
-
+
MSC 4900484 (ATR) (Slides Available)
11:00 - 11:05 | Author(s): Navid Hafez
- Abstract
No abstract available for this presentation
-
+
AZD2811 (Aurora Kinase B) (Slides Available)
11:05 - 11:10 | Author(s): Melissa Johnson
- Abstract
No abstract available for this presentation
-
+
MSC 4900484 (ATR)
11:10 - 11:15 | Author(s): Navid Hafez
- Abstract
No abstract available for this presentation
-
+
AZD1775 (WEE1) (Slides Available)
11:15 - 11:20 | Author(s): Rosalyn Juergens
- Abstract
No abstract available for this presentation
-
+
Prexasertib (Chk 1) (Slides Available)
11:20 - 11:25 | Author(s): Stephen Liu
- Abstract
No abstract available for this presentation
-
+
SRA-737 (ChK1) (Slides Available)
11:25 - 11:30 | Author(s): David Spigel
- Abstract
No abstract available for this presentation
-
+
Palbociclib (CDK4/6) (Slides Available)
11:30 - 11:35 | Author(s): David Berz
- Abstract
No abstract available for this presentation
-
+
mTOR/PI3K/Akt in Cancer and Diabetes (Slides Available)
11:35 - 11:45 | Author(s): Fadlo Khuri
- Abstract
No abstract available for this presentation
first
prev